Pill before surgery aims to shrink skin cancer, reduce facial scarring
NCT ID NCT03534947
Summary
This study tested a new approach for people with basal cell carcinoma (a common skin cancer) in sensitive areas like the face. Patients took a daily pill called sonidegib for 12 weeks before surgery. The goal was to shrink the tumor so the surgery would be smaller, cause less scarring, and potentially be avoided altogether. The study involved 16 participants and used a special skin scan to measure results.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BASAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Melanoma Institute Australia
North Sydney, New South Wales, 2060, Australia
Conditions
Explore the condition pages connected to this study.